
Liquidia Corporation Common Stock
LQDA
LQDA: Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.
moreShow LQDA Financials
Recent trades of LQDA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LQDA's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on LQDA's company Twitter account
Number of mentions of LQDA in WallStreetBets Daily Discussion
Recent insights relating to LQDA
Recent picks made for LQDA stock on CNBC
ETFs with the largest estimated holdings in LQDA
Flights by private jets registered to LQDA